Myosteatosis is prognostic in metastatic melanoma treated with nivolumab
Susie Youn, Rebecca Reif, Michael P. Chu, Michael Smylie, John Walker, Dean T. Eurich, Sunita Ghosh, Michael B. Sawyer
Topics & Concepts
MedicineNivolumabMetastatic melanomaOncologyMelanomaInternal medicineCancer researchCancerImmunotherapyCutaneous Melanoma Detection and ManagementCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways